The aim of this study is to investigate the role of anti-α-actinin antibodies in patients with new-onset systemic lupus erythematosus (SLE). Thirty-six patients with SLE, 16 of whom had lupus nephritis (LN), and 53 healthy controls were included. The clinical and laboratory parameters of patients were collected from medical records or by questionnaire. Serum anti-α-actinin Abs was measured by competitive enzyme linked immunosorbent assay (ELISA). Our results show that the OD value of serum anti-α-actinin Abs in SLE patients was significantly lower than that in normal controls (1.212 ± 0.244 vs. 1.364 ± 0.202, P = 0.002); seven of 36 SLE patients were seropositive for anti-α-actinin Abs, which was significantly higher than in normal controls (19.4 vs. 3.8%, P = 0.028). There were no significant differences of clinical parameters between the anti-α-actinin Abs-positive patients and the negative patients. The positive rate of the term urine casts, elevated IgM and IgA in anti-α-actinin Abs-positive patients were higher than that in the negative patients. The OD values of serum anti-α-actinin Abs negatively correlated with disease activity (R s = −0.352, P = 0.035). Anti-α-actinin Abs may be a useful marker of the disease activity of SLE; in addition, it may be used as a complementary parameter to differentiate LN from SLE without nephritis.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Pan HF, Ye DQ, Li XP (2008) Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol 4:352–353
Linnik MD, Hu JZ, Heilbrunn KR et al (2005) Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 52:1129–1137. doi:10.1002/art.20980
Rekvig OP, Kalaaji M, Nossent H (2004) Anti-DNA antibody subpopulations and lupus nephritis. Autoimmun Rev 3:1–6. doi:10.1016/S1568-9972(03)00081-8
Renaudineau Y, Deocharan B, Jousse S et al (2007) Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun Rev 6:464–468. doi:10.1016/j.autrev.2007.02.001
Zhao Z, Deocharan B, Scherer PE et al (2006) Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin. J Immunol 176:7704–7714
Dixson JD, Forstner MJ, Garcia DM (2003) The alpha-actinin gene family: a revised classification. J Mol Evol 56:1–10. doi:10.1007/s00239-002-2374-5
Becker-Merok A, Kalaaji M, Haugbro K et al (2006) Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Arthritis Res Ther 8:R162. doi:10.1186/ar2070
Mason LJ, Ravirajan CT, Rahman A et al (2004) Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum 50:866–870. doi:10.1002/art.20103
Deocharan B, Qing X, Lichauco J et al (2002) Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168:3072–3078
Mostoslavsky G, Fischel R, Yachimovich N et al (2001) Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 31:1221–1227. doi:10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P
Migliorini P, Pratesi F, Bongiorni F et al (2002) The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun Rev 1:168–173. doi:10.1016/S1568-9972(02)00028-9
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277. doi:10.1002/art.1780251101
Pan HF, Fang XH, Wu GC et al (2008) Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis. Inflammation 31:260–265. doi:10.1007/s10753-008-9073-3
Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640. doi:10.1002/art.1780350606
Renaudineau Y, Croquefer S, Jousse S et al (2006) Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum 54:2523–2532. doi:10.1002/art.22015
Croquefer S, Renaudineau Y, Jousse S et al (2005) The anti-alpha-actinin test completes anti-DNA determination in systemic lupus erythematosus. Ann N Y Acad Sci 1050:170–175. doi:10.1196/annals.1313.017
Kalaaji M, Sturfelt G, Mjelle JE et al (2006) Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum 54:914–926. doi:10.1002/art.21622
Renaudineau Y, Dalekos GN, Guéguen P et al (2008) Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis. Clin Rev Allergy Immunol 34:321–325. doi:10.1007/s12016-007-8050-1
This work was supported by grants from the National Natural Science Foundation of China (30571608, 30771848), the key program of National Natural Science Foundation of China (30830089). We are deeply indebted to the people who have participated in this study.
About this article
Cite this article
Zhang, WH., Pan, HF., Zhao, XF. et al. Anti-α-actinin antibodies in relation to new-onset systemic lupus erythematosus and lupus nephritis. Mol Biol Rep 37, 1341–1345 (2010). https://doi.org/10.1007/s11033-009-9513-7
- Anti-α-actinin antibodies
- Systemic lupus erythematosus
- Disease activity